Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × alectinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Neoplasms 4 Lung Neoplasms 4 Solid Tumors 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Hematologic Neoplasms 1 Genomic Instability 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 ALK+ Advanced NSCLC 1

Interventions

Gemcitabine 29 Cisplatin 28 durvalumab 17 pembrolizumab 13 Leucovorin 11 Oxaliplatin 10 Fluorouracil 9 Capecitabine 9 Nivolumab 8 lenvatinib 7 Bevacizumab 6 zanidatamab 4 Liquid Biopsy 4 Folfox protocol 4 Carboplatin 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 tislelizumab 3 irinotecan sucrosofate 3 Trastuzumab 3 S 1 (combination) 3 Injections 3 pertuzumab 2 niraparib 2 ivosidenib 2 gemcitabine-oxaliplatin regimen 2 envafolimab 2 brigimadlin 2 atezolizumab 2 Tegafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡